Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
18 drugs in development
By Therapeutic Area
top 6
R&D Momentum
94/100
Pipeline Velocity
76/100
Trial Completion Rate
71/100
Pipeline Concentration
24/100
Pipeline Freshness
68/100
Strategic Signals
Activity
Last 14 days
Precision Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Cognitive Enhancement Through Computerized Training
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Rescuing Mobility Function Through Surgical Removal of the Parathyroid Gland
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
Genetic Biomarkers of Intermittent Hypoxia-Induced Respiratory Motor Plasticity in Chronic SCI
ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses (CASPIAN)
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
A Randomized Control Trial Studying the Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis:
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)